Sirnaomics Ltd. announced that its board resolved on 24 March 2026, after trading hours, to seek shareholder approval for terminating the 2022 Restricted Share Unit (RSU) Scheme and adopting a new 2026 RSU Scheme at an upcoming extraordinary general meeting (EGM).
The existing 2022 RSU Scheme, adopted on 22 April 2022 with a 10-year term, currently has 8,962 outstanding RSUs. These units will remain valid and exercisable under the original rules even after the scheme’s termination, which requires an ordinary resolution of shareholders.
Management attributes the replacement to amendments to Chapter 17 of the Hong Kong Listing Rules that took effect on 1 January 2023. The proposed 2026 RSU Scheme will be treated as a share scheme involving the issue of new shares, bringing it into alignment with the updated regulatory framework.
Implementation of the 2026 RSU Scheme is conditional upon: 1. Shareholder approval at the EGM, including authorisation for the board to grant RSUs and allot and issue any resulting shares; and 2. Approval from the Hong Kong Stock Exchange’s Listing Committee for the listing of, and permission to deal in, shares to be issued under the new scheme.
A circular detailing the termination of the 2022 RSU Scheme, the principal terms of the 2026 RSU Scheme, and the EGM notice will be dispatched to shareholders as required by the Listing Rules. The company advises investors to exercise caution when dealing in its securities until the proposals are approved.
Comments